Related Experiment Video

Updated: Jun 30, 2025

Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

960

Analysis of innovative two-stage seamless adaptive design with different endpoints and population shift

Weijia Mai1, Shein-Chung Chow1

  • 1Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.

Journal of Biopharmaceutical Statistics
|March 22, 2024
PubMed

Insights

This study presents a new statistical method for analyzing two-stage seamless adaptive trial designs. It addresses complex scenarios with changing patient populations and endpoints, crucial for modern drug development.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Drug Development

Background:

  • Two-stage seamless adaptive trial designs are increasingly used in drug development, often combining Phase 2 dose-finding with Phase 3 efficacy studies.
  • Existing statistical methods for simpler group sequential designs are frequently misapplied to these complex adaptive designs.
  • Chow (2020) categorized these designs based on variations in patient populations, objectives, and endpoints across stages.

Purpose of the Study:

  • To propose a statistical analysis method for two-stage seamless adaptive trials.
  • To address designs with differing study endpoints and shifted patient populations between stages.
  • To provide a method applicable to trials with protocol amendments or disease progression.

Main Methods:

  • The study proposes a statistical method based on the assumption of a known relationship between study endpoints.
  • It builds upon statistical concepts from Chow and Lin (2015) and Chow (2020).
  • The method is designed for the analysis of two-stage seamless adaptive designs with distinct characteristics in each stage.

Main Results:

  • A statistical method is discussed for analyzing complex two-stage seamless adaptive trial designs.
  • The method accounts for variations in study endpoints and target patient populations.
  • It offers a viable approach for data analysis in challenging clinical trial scenarios.

Conclusions:

  • The proposed statistical method is suitable for analyzing two-stage seamless adaptive trials with differing endpoints and patient populations.
  • This approach is valuable for clinical trials involving protocol amendments or disease progression.
  • Accurate statistical analysis is essential for the successful implementation of adaptive trial designs in drug development.
Keywords:
Multiple-stage seamless adaptive designcontrol of type I error ratepopulation shiftprotocol amendmentsample size allocation

More Related Videos

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.5K
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.5K

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
99
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
231
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
215